Intersect ENT
14
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
36%
5 trials in Phase 3/4
93%
13 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
A Clinical Evaluation of PROPEL® Contour Sinus Implant
Role: lead
A Clinical Evaluation of the Intersect ENT Sinus Device (ASCEND)
Role: lead
A Clinical Evaluation of the Sinexus Intranasal Splint Following Functional Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis
Role: lead
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)
Role: lead
In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia
Role: lead
The PIO II Study: In-office Post-op Placement of a Steroid-eluting Sinus Implant
Role: collaborator
Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus
Role: lead
S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps
Role: lead
Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps
Role: lead
Safety and Performance of the Steroid-Releasing S8 Sinus Implant
Role: lead
Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia
Role: lead
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
Role: collaborator
A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis
Role: lead
Clinical Evaluation of the Steroid-Eluting Sinexus Intranasal Splint When Used Following Functional Endoscopic Sinus Surgery (FESS) in Patients With Chronic Sinusitis
Role: lead
All 14 trials loaded